Business / Finance

RSS

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

Xenogenics Corporation, a majority owned subsidiary of MultiCell Technologies, Inc., is pleased to announce it has retained the Emmes Group to assist with the development and execution of its capital formation strategy to help finance expanded human clinical trials of its Ideal BioStent.

24 Feb 2011

Pharmagesic to acquire WEX shares

Pharmagesic Inc. announced today that the offer by its wholly-owned subsidiary, 7735308 Canada Limited to acquire all of the outstanding restricted voting shares of WEX Pharmaceuticals Inc. not already owned by Pharmagesic for C$0.14 cash per WEX Share has been extended to 5:00 p.m. on March 10, 2011.

23 Feb 2011

GTCR to acquire Sterigenics International

GTCR, a leading private equity firm, today announced it has signed a definitive agreement with Silverfleet Capital and PPM America Capital Partners to acquire Sterigenics International, the leading global provider of contract sterilization and ionization services for medical devices, food products, and advanced applications.

23 Feb 2011

Intercell places EUR 33.0m of Senior Unsecured Convertible Notes in private placement transaction

Intercell AG today announced that it successfully placed EUR 33.0m of Senior Unsecured Convertible Notes in a private placement transaction, which was increased due to investor demand.

23 Feb 2011

PPD, Elan establish strategic collaboration to execute clinical programs

Elan, plc and PPD, Inc. today announced they have formed a global business collaboration focused on the advancement, progression and execution of Elan's development portfolio.

23 Feb 2011

Town Sports fourth quarter total revenue decreases 0.2%

Town Sports International Holdings, Inc., a leading owner and operator of health clubs located primarily in major cities from Washington, DC north through New England, operating under the brand names "New York Sports Clubs," "Boston Sports Clubs," "Washington Sports Clubs" and "Philadelphia Sports Clubs," announced its results for the fourth quarter and full-year ended December 31, 2010.

23 Feb 2011

Gilead Sciences signs definitive agreement to acquire Calistoga for $375 million

Gilead Sciences, Inc. and Calistoga Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of medicines to treat cancer and inflammatory diseases, today announced the signing of a definitive agreement pursuant to which Gilead will acquire Calistoga for $375 million.

22 Feb 2011

Forest Labs enters definitive merger agreement to acquire Clinical Data

Forest Laboratories, Inc. and Clinical Data, Inc. today announced that they have entered into a definitive merger agreement pursuant to which Forest will acquire Clinical Data, a specialty pharmaceutical company focused on the development of first-in-class and best-in-category therapeutics, for $30.00 per share in cash plus contingent consideration of up to $6.00 per share that may be paid upon achievement of certain commercial milestones related to Viibryd.

22 Feb 2011

Henry Schein fourth quarter net sales increase 15.1% to $7.5 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended December 25, 2010.

22 Feb 2011

NHC announces net income of $3.22 per share for year ended Dec. 31, 2010

National HealthCare Corporation, one of the nation's oldest long-term health care companies, today announced net income available to common shareholders of $44,022,000 or $3.22 per share basic for the year ended Dec. 31, 2010, compared to $31,376,000 or $2.31 per share basic for the year ended Dec. 31, 2009, an increase of 40.3%.

22 Feb 2011

Johnson & Johnson completes cash tender for Crucell shares, declares offer unconditional

Johnson & Johnson and Crucell N.V. today announce that Johnson & Johnson has completed the tender offer for Crucell N.V. and has declared the offer unconditional.

22 Feb 2011

Kronos announces additional details regarding pending acquisition of API Healthcare at HIMSS conference

Kronos Incorporated today announced additional details regarding its pending acquisition of API Healthcare Corporation to organizations attending the HIMSS conference being held this week. The closing of the transaction is subject to regulatory approval and customary closing conditions.

22 Feb 2011

Urgent Cares of America acquires Urgent Care Express

Urgent Cares of America Holdings, LLC (UCA) today announced the acquisition of Tri-City Express Care, PLLC (d.b.a. Urgent Care Express) (UCE) based in Gilbert, Arizona with five urgent care locations in the Phoenix area. The acquisition represents the first step in UCA’s strategy to build a national group of urgent care clinics that are driven by clinical and operational best practices.

21 Feb 2011

GE Healthcare completes Orbotech Medical acquisition

GE Healthcare, a unit of General Electric Company, announced that it has completed the acquisition of the assets of Orbotech Medical Solutions Ltd. (OMS), a subsidiary of Orbotech Ltd. (Orbotech), and a manufacturer of cadmium zinc telluride (CZT) detectors used in GE Healthcare's innovative Alcyone nuclear medicine technology.

21 Feb 2011

Best Medical Belgium to purchase Nordion's Belgian operations

Nordion Inc., a leading provider of products and services to the global health science market, today announced it has signed a share purchase agreement (SPA) with Best Medical Belgium (Best Medical) for the divestiture of the Company's Belgian operations, MDS Nordion S.A. Pursuant to the SPA, Best Medical will acquire all of Nordion's Belgian operations with the exception of the TheraSphere® business.

21 Feb 2011

TMS moves its headquarters to Primera Office Park in Lake Mary, Fla

Total Medical Solutions has moved its headquarters into a 10,000-square-foot space in the Primera Office Park in Lake Mary, Fla.

21 Feb 2011

Sheffield Bio-Science forms strategic alliance with Wockhardt to strengthen cell culture media portfolio

Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for recombinant insulin manufactured by global Indian biotech Wockhardt. According to estimates, the potential in cell culture markets is around US$ 50 million.

21 Feb 2011

Elsevier acquires Shanghai Datong Medical Information Technology

Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of Shanghai Datong Medical Information Technology Co., Ltd., a leading drug decision support provider in China.

21 Feb 2011

Meda signs agreement to acquire Antula

Meda has signed an agreement to acquire Antula with well-known brands such as SB12, Anti, Zyx, Becur, Ac3, Lactal Balans, Eeze, Nalox, and Inside.

21 Feb 2011

dbMotion announces contract awards with numerous healthcare organizations

dbMotion, an innovative provider of connected healthcare solutions, announced contract awards with numerous healthcare organizations including Orlando Health; University Hospitals of Cleveland, Ohio; Sharp Healthcare and Huntington Memorial Hospital in 2010, underscoring the company's accelerated growth among providers seeking to achieve genuinely connected healthcare.

21 Feb 2011